논문상세정보
' The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Diabetes mellitus
  • Non-alcoholic fatty liver Disease
  • prediabetic state
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
428 0

0.0%

' The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease' 의 참고문헌

  • The global epidemiology of NAFLD and NASH in patients with type 2 diabetes : a systematic review and meta-analysis
    Younossi ZM [2019]
  • The fatty liver index : a simple and accurate predictor of hepatic steatosis in the general population
    Bedogni G [2006]
  • The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American association for the study of liver diseases
  • The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments
    Targher G [2021]
  • The Relative Merits of Risk Ratios and Odds Ratios
  • Standards of Medical Care in Diabetes—2015: Summary of Revisions
    undefined [2014]
  • Sodium-glucose co-transporter 2 inhibitors for non-alcoholic fatty liver disease in Asian patients with type 2 diabetes: a meta-analysis
    Wong C [2021]
  • Prevalence and predictors of non-alcoholic fatty liver disease in prediabetes
    Rajput R [2019]
  • Prediction of NAFLD occurrence in prediabetes patients
    Vesa CM [2020]
  • Prediabetes diagnosis and treatment : a review
    Bansal N [2015]
  • Prediabetes : a high-risk state for diabetes development
    Tabák AG [2012]
  • Pre-diabetes and NAFLD; a study of an Algerian population sample
  • Past, present and future perspectives in nonalcoholic fatty liver disease
    Sanyal AJ [2019]
  • Noninvasive biomarkers in NAFLD and NASH-current progress and future promise
    Wong VW [2018]
  • Nonalcoholic fatty liver disease and cardiovascular disease
  • Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
  • Non-alcoholic fatty liver disease and risk of incident diabetes mellitus : an updated meta-analysis of 501 022 adult individuals
    Mantovani A [2021]
  • Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events : an updated systematic review and meta-analysis
    Mantovani A [2021]
  • Methods for estimating adjusted risk ratios
    Cummings P [2009]
  • Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease
    Xiao J [2021]
  • Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis : an updated meta-analysis of randomized controlled trials
    Mantovani A [2021]
  • Global epidemiology of prediabetes-present and future perspectives
    Hostalek U [2019]
  • Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey
    Ruhl CE [2015]
  • Diabetes and cardiovascular disease : an update
    Almourani R [2019]
  • Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma : a systematic review and meta-analysis
    Tan DJH [2022]
  • Chronic kidney disease
    Levey AS [2012]
  • Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission
    Wild SH [2018]
  • Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
    Mallet V [2022]
  • Association of diabetes with all-cause and cause-specific mortality in Asia : a pooled analysis of more than 1 million participants
    Yang JJ [2019]
  • Association between diabetes mellitus and all-cause and cardiovascular mortality among individuals with ultrasound-defined non-alcoholic fatty liver disease
    Wu W [2021]
  • Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
  • Antidiabetic medications for type 2 diabetics with nonalcoholic fatty liver disease : evidence from a network meta-analysis of randomized controlled trials
    Ng CH [2022]
  • An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
  • A clinical overview of non-alcoholic fatty liver disease : a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know
    Muthiah MD [2022]
  • A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019
  • 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis